Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the …
Background Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of patients
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
[引用][C] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors …
CB Granger, JJ McMurray, S Yusuf, P Held… - Lancet, 2003 - ueaeprints.uea.ac.uk
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular
systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative …
systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-alternative …
[引用][C] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors …
G CB - Lancet, 2003 - cir.nii.ac.jp
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic
function intolerant to angiotensin-converting-enzyme inhibitors : the CHARM-Alternative trial …
function intolerant to angiotensin-converting-enzyme inhibitors : the CHARM-Alternative trial …
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the …
CB Granger, JJV McMurray, S Yusuf… - Lancet (London …, 2003 - pubmed.ncbi.nlm.nih.gov
Background Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of patients
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the …
CB Granger, JJV McMurray, S Yusuf, P Held… - The Lancet, 2003 - thelancet.com
Background Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of patients
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the …
CB Granger, JJ McMurray, S Yusuf, P Held… - Lancet (London …, 2003 - europepmc.org
Background Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of patients
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
[PDF][PDF] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors …
CB Granger, JJV McMurray, S Yusuf, P Held… - THE LANCET, 2003 - cardiacbc.ca
Background Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of patients
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
with chronic heart failure (CHF). A substantial proportion of patients, however, experience no …
[引用][C] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors …
CB Granger, JJV McMurray, S Yusuf, P Held… - Lancet, 2003 - eprints.gla.ac.uk
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic
function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial …
function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial …
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the …
CB Granger, JJV McMurray, S Yusuf, P Held… - The Lancet, 2003 - Elsevier
BACKGROUND: Angiotensin-converting-enzyme (ACE) inhibitors improve outcome of
patients with chronic heart failure (CHF). A substantial proportion of patients, however …
patients with chronic heart failure (CHF). A substantial proportion of patients, however …
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The …
CB Granger, JJV McMurray, S Yusuf, P Held - The Lancet, 2003 - elibrary.ru
There were 265 deaths from any cause in the candesartan group, and 296 in the placebo
group (unadjusted 0 [middot] 87 [0 [middot] 74-1 [middot] 03], p= 0 [middot] 11; covariate …
group (unadjusted 0 [middot] 87 [0 [middot] 74-1 [middot] 03], p= 0 [middot] 11; covariate …